Nouscom

About:

Nouscom is a biotech company working to develop a series of immunotherapeutics capable of selectively killing tumor cells.

Website: http://www.nouscom.com

Top Investors: Andera Partners, Bpifrance, EQT Life Sciences, Versant Ventures, Revelation Partners

Description:

Nouscom is a developer of an immunotherapy platform that aims to create modified viral vector vaccines for cancer treatment. The company's platform makes use of a portfolio of engineered viral vectors that have been optimized for the efficient expression of long strings of tumor neoantigens. It also includes a toolkit for inducing broad and potent antitumor T-cell responses, allowing patients to boost cancer-specific cellular immunity.